In this context, the low molecular weight dodecapeptide GE11 (YHWYGYTPQNVI) has been demonstrated to have a high affinity for EGFR.17 Then, many analogs of the GE11 peptide were screened to search for a peptide with the highest affinity for EGFR using triple negative breast cancer cells (MDA-MB-231 line) overexpressing this receptor as a model. Here, EGFR is linked to triple-negative breast carcinoma.